A Study of Avastin (Bevacizumab) in Combination Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
A study of Avastin (bevacizumab) in combination chemotherapy in patients with metastatic
cancer of the colon or rectum. The anticipated time on study treatment is until disease
progression.